(19)
(11) EP 1 218 347 A1

(12)

(43) Date of publication:
03.07.2002 Bulletin 2002/27

(21) Application number: 00955709.1

(22) Date of filing: 19.08.2000
(51) International Patent Classification (IPC)7C07D 231/54, C07D 401/04, C07D 413/04, C07D 401/12, C07D 409/12, A61K 31/415
(86) International application number:
PCT/US0022/727
(87) International publication number:
WO 0112/609 (22.02.2001 Gazette 2001/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 19.08.1999 US 378234

(71) Applicant: SIGNAL PHARMACEUTICALS, INC.
San Diego, CA 92121 (US)

(72) Inventors:
  • BENNETT, Brydon, L.
    San Diego, CA 92117 (US)
  • BHAGWAT, Shripad, S.
    San Diego, CA 92130 (US)
  • MANNING, Anthony, M.
    San Diego, CA 92129 (US)
  • MURRAY, Brion, W.
    San Diego, CA 92106 (US)
  • O'LEARY, Eoin, C.
    San Diego, CA 92116 (US)
  • SATOH, Yoshitaka
    San Diego, CA 92131 (US)

(74) Representative: Jump, Timothy John Simon et al
Venner Shipley & Co.20 Little Britain
London EC1A 7DH
London EC1A 7DH (GB)

   


(54) PYRAZOLOANTHRONE AND DERIVATIVES THEREOF AS JNK INHIBITORS AND THEIR COMPOSITIONS